All News

From comedian Chris Tucker teaming up with a nonprofit to educate Black men on their prostate cancer risk to Leeane Hainby and Rep. Jamie Raskin providing updates on their cancer treatment, here’s what’s happening in the cancer space this week.

The novel targeted radiotherapy iomab-B led to the disappearance of all signs of cancer and an improvement in event-free survival compared with physician’s choice of treatment.

The designation is based on study findings demonstrating that the cancer vaccine-Keytruda combination reduces the risk of recurrence or death by 44% in the adjuvant setting for patients with melanoma.

Karen Estrada was shocked when she was diagnosed with leukemia and ended up on a lifesaving clinical trial, although her journey was not entirely smooth.

As unlucky as I was to be diagnosed with pancreatic cancer, I'm extremely thankful to still be here today.

Patients who used opioids long-term after undergoing an autologous stem cell transplant tended to have poorer survival outcomes, recent research showed.

Standard corticosteroid use may not be the best treatment for patients with cancer who experience immunotherapy-related heart issues, research showed.

A book I read made me realize the importance of positive thinking — even when going through cancer.

Patients with type 2 diabetes have an increased cancer burden and, as a result, a higher mortality rate, highlighting the importance of inflammatory factors like obesity and glucose control.

An expert explains what patients with low-grade prostate cancer can expect when undergoing genomic testing — and why the procedure is important.

Important data may encourage gender-specific treatment making decisions for patients with bladder cancer.

A clinical trial is currently enrolling patients who are experiencing hand-foot skin reaction as a result of kidney cancer treatment.

An expert discusses the value of Jaypirca’s recent accelerated FDA approval for relapsed/refractory mantle cell lymphoma, as well as where treatment may go next.

Sometimes the steps I take leaving the hospital make me feel like I’m flying if I received good news, but other times, I’m walking quickly to my car before I begin to cry.

After receiving supportive care during her college cancer journey, this survivor now works to guide other patients through their treatments.

We cancer survivors are complicated — not more complicated than others who have faced their mortality head-on, but there’s a certain bucket we get put in when we let others know about our diagnoses.

Chemotherapy affected my brain in ways that I was never told about.

Patients with cancer should keep a healthy heart during cancer treatment by exercising regularly and eating healthy, an expert emphasized.

In 2023, my goal is to continue building my role as a patient advocate and to support other cancer survivors in the fight through the various organizations I am involved with.

The addition of Tecentriq to platinum-based chemotherapy/gemcitabine did not boost outcomes in patients with metastatic bladder cancer, according to results from the IMvigor 140 trial.

The addition of Cabometyx to Opdivo and Yervoy improved outcomes for patients with advanced kidney cancer, according to recent research.

Researchers identified several biomarkers that may indicate how a patient responds to Padcev, a type of antibody drug conjugate for patients with urothelial carcinoma, a type of bladder cancer.

When I was undergoing cancer treatment, writing was a creative outlet that helped calm my nerves.

The combination demonstrated survival benefit in patients with metastatic hormone-sensitive prostate cancer, regardless of risk or volume of disease.

In honor of National Caregivers’ Day, CURE® took a look back at some of our most popular content from and about cancer caregivers.

Cancer often brings with it bad news, including expensive bills, but one day, a surprise came – one I’ll never forget.

From Senator Bob Casey undergoing prostate cancer surgery to a man giving away his Superbowl tickets to a good friend with stage 4 cancer, here’s what is happening in the oncology space this week.

The administration of Pluvicto within six months of radium-223 treatment proved to be safe and efficacious in patients with metastatic castration-resistant prostate cancer, research showed.